Anteris Technologies (AVR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
18 May, 2026Executive summary
Special Meeting of Stockholders postponed from September 4, 2025, to September 11, 2025, to allow more time for shareholder voting and broader participation.
The record date for voting eligibility remains August 11, 2025.
The meeting will be held virtually, and prior votes remain valid unless changed by the shareholder.
Forward-looking statements caution about uncertainties regarding quorum and stockholder approval.
Voting matters and shareholder proposals
Board unanimously recommends voting FOR the proposals outlined in the definitive Proxy Statement filed August 18, 2025.
Voting instructions and deadlines are provided for both Common Stock and CHESS Depositary Interests holders.
Board of directors and corporate governance
Board of Directors is actively facilitating broader shareholder participation by postponing the meeting.
Latest events from Anteris Technologies
- Shareholders considered and voted on a US redomicile scheme, with board and expert support.AVR
Share Scheme Meeting9 Jul 2026 - Option holders voted on a scheme to exchange their options for equivalent securities in ATGC.AVR
Option Scheme Meeting8 Jul 2026 - US IPO, clinical milestones, and strong R&D focus marked a pivotal year.AVR
AGM 20258 Jul 2026 - Operating losses widened as PARADIGM Trial preparations accelerated and cash fell to $28.4M.AVR
Q2 2025 TU18 May 2026 - Pre-commercial heart device company targets U.S. IPO to fund pivotal trials amid high growth potential and risk.AVR
Registration filing18 May 2026 - Raising $90.6M to fund heart valve trials, but faces ongoing losses and high risk.AVR
Registration filing18 May 2026 - 2024 net loss rose to $76M, cash insufficient for 12 months, additional funding required.AVR
H2 202418 May 2026 - Net loss rose 36% to $21.9M as R&D and trial costs surged, straining cash reserves.AVR
Q1 202518 May 2026 - Stockholders to vote on ASX waiver for new securities issuances and possible meeting adjournment.AVR
Proxy filing18 May 2026